PlainRecalls
FDA Drug Moderate Class II Terminated

Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1013-68

Reported: February 10, 2016 Initiated: January 11, 2016 #D-0648-2016

Product Description

Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1013-68

Reason for Recall

FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.

Details

Recalling Firm
Pfizer Inc.
Units Affected
30,672 bottles
Distribution
Nationwide and Puerto Rico
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1013-68. Recalled by Pfizer Inc.. Units affected: 30,672 bottles.
Why was this product recalled?
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 10, 2016. Severity: Moderate. Recall number: D-0648-2016.